8-K: Cannabist Co Holdings Reaches Agreement to Extend Senior Secured Notes Maturity to December 2028

Sentiment:

8-K Filing


Cannabist Co Holdings Inc. has entered into a support agreement with noteholders to extend the maturity date of its senior secured notes to December 2028, with options for further extension.

Capital raiseThe company will issue 118,209,105 common shares (the New Shares), representing 24.99% of the issued and outstanding shares of the Company, on a pro rata basis to holders of Senior Notes who elect to receive New Senior Notes (the Share Payment).In order to reduce the dilutive effect of the New Shares on existing shareholders of the Company, the existing shareholders of the Company (excluding the recipients of the New Shares) will be granted new common share purchase warrants (the Anti-Dilutive Warrants) to acquire an aggregate of 118,246,947 million newly issued common shares, representing approximately 20% of the common shares on a pro forma, diluted basis (after taking into consideration the issuance of the New Shares).The Anti-Dilutive Warrants will be exercisable at CDN$0.14 per common share for a period of two years from the closing of the Transaction.

Summary

  • The Cannabist Company Holdings Inc. has entered into a support agreement with certain noteholders representing approximately 61% of the aggregate principal amount of issued Senior Notes.
  • The agreement involves exchanging existing Senior Notes for new notes with a later maturity date and additional covenants.
  • The Senior Notes consist of $59.5 million in 6.0% Senior Secured Convertible Notes due June 29, 2025, $185 million in 9.5% Senior Secured First-Lien Notes due February 3, 2026, and $25.55 million in 9.0% Senior Secured Convertible Notes due March 19, 2027, totaling approximately $270 million.
  • Holders of the 2025 and 2026 Notes will exchange their notes for an equal principal amount of 9.25% senior secured notes due December 31, 2028, with two six-month extension options available to the company upon payment of a 0.50% fee.
  • Holders of the 2027 Notes can elect to receive either an equal principal amount of the new 9.25% senior secured notes or an equal principal amount of newly issued 9.0% convertible notes with the same conversion price as the existing 2027 Notes but with the extended maturity date.
  • The company will issue 118,209,105 common shares, representing 24.99% of the issued and outstanding shares, on a pro rata basis to holders of Senior Notes who elect to receive New Senior Notes.
  • Existing shareholders will be granted new common share purchase warrants to acquire an aggregate of 118,246,947 newly issued common shares, representing approximately 20% of the common shares on a pro forma, diluted basis, exercisable at CDN$0.14 per common share for two years.
  • The transaction is subject to approval by the Ontario Superior Court of Justice and customary conditions, with a targeted closing in the first half of 2025.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While the debt restructuring provides financial flexibility, the dilution from share issuance and new covenants introduce some concerns. The extension of debt maturities is a positive step, but the company's future performance will depend on its ability to execute its strategic plan.

Positives

  • Extending the maturity of the senior debt provides the company with additional financial flexibility and runway to execute its strategic plan.
  • The agreement with noteholders representing a significant portion of the outstanding Senior Notes indicates strong support for the company's restructuring efforts.
  • The issuance of new warrants to existing shareholders aims to mitigate the dilutive effect of the new shares issued to noteholders.
  • The addition of two independent directors nominated by the Supporting Noteholders enhances corporate governance.
  • The early consent fee and asset sale consent fee provide additional incentives for noteholders to support the transaction.

Negatives

  • The issuance of 118,209,105 common shares to noteholders will dilute existing shareholders' equity.
  • The new notes will contain new covenants, including a net consolidated leverage ratio requirement and minimum liquidity requirement, which may restrict the company's operational flexibility.
  • The transaction is subject to court and regulatory approvals, which introduces uncertainty and potential delays.
  • The company's option to pay the early consent consideration in cash or through transfer of publicly traded securities of a third-party issuer owned by the company, at the company's option, may be viewed negatively if the company chooses to transfer securities of questionable value.

Risks

  • The company may not receive the necessary approvals to complete the transaction.
  • Failure to meet the new covenants in the notes could trigger an event of default.
  • Delays in closing the transaction could negatively impact the company's financial performance.
  • The value of the new warrants issued to existing shareholders may be affected by market conditions and the company's performance.
  • The company's ability to generate sufficient cash flow to meet its debt obligations is subject to various factors, including market conditions and regulatory changes.

Future Outlook

The company is targeting closing the transaction in the first half of 2025, subject to the satisfaction of closing conditions, including court approval of the plan and the receipt of any necessary state cannabis regulatory approvals. The company intends to mail a proxy circular in the upcoming weeks to holders of Senior Notes.

Management Comments

  • David Hart, CEO of The Cannabist Company, stated that the agreement with bondholders to extend the maturities of the senior debt until December 2028 positions the company with runway to continue to execute against its strategic plan.
  • David Hart, CEO of The Cannabist Company, mentioned that the company is grateful for the partnership with its bondholders and looks forward to making further progress as it builds a better business.

Industry Context

This announcement reflects a trend in the cannabis industry where companies are restructuring their debt to improve their financial stability and position themselves for future growth. Many cannabis companies face challenges in accessing traditional financing due to regulatory hurdles and market volatility, making debt restructuring a common strategy.

Comparison to Industry Standards

  • Debt restructuring and maturity extensions are common strategies employed by cannabis companies facing financial challenges, similar to actions taken by companies like Canopy Growth and Aurora Cannabis in recent years.
  • The interest rates on the new notes (9.25% and 9.0%) are within the typical range for secured debt in the cannabis industry, reflecting the higher risk associated with the sector.
  • The issuance of warrants to existing shareholders to mitigate dilution is a standard practice in restructuring transactions, similar to strategies used in other industries.
  • The governance changes, including the addition of independent directors nominated by noteholders, are in line with best practices for corporate governance and are often a condition of debt restructuring agreements.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionAt closing of the Transaction, the Company will select two (2) qualified independent directors with no affiliation to competitors (the Independent Directors) from a slate of candidates provided by the Supporting Noteholders, to be added to the board of directors of the Company (the Board).Closing of the TransactionEnhances board independence and provides noteholders with greater oversight.
Board SizeFour (4) of the Company's director positions will be eliminated as of the 2025 annual general meeting if closing has occurred by such meeting, resulting in a seven-person board (pro forma for the addition of two (2) new Independent Directors described above).2025 annual general meetingStreamlines board operations and potentially reduces costs.
Board Chair ApprovalThe Chair of the Board shall be subject to approval by the independent directors of the Board.Closing of the TransactionEnsures independent oversight of board leadership.

Legal Proceedings

  • The Transaction will be subject to approval by the Ontario Superior Court of Justice pursuant to a plan of arrangement (the Plan) under the Canada Business Corporations Act (the CBCA).

Stakeholder Impact

  • Shareholders will experience dilution from the issuance of new shares to noteholders, but may benefit from the company's improved financial stability and future growth prospects.
  • Noteholders will receive new notes with extended maturity dates and potentially improved security, but will also be subject to new covenants.
  • Employees may benefit from the company's improved financial stability and ability to invest in future growth.
  • Customers and suppliers may experience minimal impact, as the debt restructuring is primarily a financial transaction.

Next Steps

  • The company intends to mail a proxy circular to holders of Senior Notes to approve the transaction.
  • The company will seek approval from the Ontario Superior Court of Justice for the plan of arrangement.
  • The company will work to satisfy the closing conditions, including obtaining necessary regulatory approvals.
  • The company will select two qualified independent directors with no affiliation to competitors from a slate of candidates provided by the Supporting Noteholders, to be added to the board of directors of the Company.

Key Dates

DateDescription
May 14, 2020Date of the original trust indenture between The Cannabist Company and Odyssey Trust Company.
June 29, 2025Original maturity date of the 6.0% Senior Secured Convertible Notes (2025 Notes).
February 3, 2026Original maturity date of the 9.5% Senior Secured First-Lien Notes (2026 Notes).
March 19, 2027Original maturity date of the 9.0% Senior Secured Convertible Notes (2027 Notes).
December 31, 2028New maturity date for the 9.25% senior secured notes and the new 9.0% convertible notes.
February 27, 2025Date of the support agreement between The Cannabist Company Holdings Inc. and the Supporting Noteholders.
March 10, 2025Deadline for holders of Senior Notes to execute a joinder to the Support Agreement to become Early Supporting Noteholders and receive the Early Consent Consideration.
March 24, 2025Milestone date to finalize the A&R Indenture and file the application in the Proceedings seeking the Interim Order.
May 5, 2025Milestone date to obtain Court approval of the Final Order.
June 1, 2025Outside Date for consummating the Transaction, subject to potential extensions.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.